Clinical Trial Update: Fecal Microbiota Transplantation in aGvHD After ASCT [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial, sponsored by the Medical University of Graz, is evaluating fecal microbiota transplantation for acute graft-versus-host disease aff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Medical University of Graz | Conditions: Graft Versus Host Disease in GI Tract | Phase 3 | Status: RECRUITING